Pòster a #Docusalut: In vitro evolutionary potential of TEM β-lactamases in Neisseria gonorrhoeae under β-lactam antibiotic pressure https://hdl.handle.net/20.500.13003/27323 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
September 14, 2026 at 6:30 PM
Pòster a #Docusalut: In vitro evolutionary potential of TEM β-lactamases in Neisseria gonorrhoeae under β-lactam antibiotic pressure https://hdl.handle.net/20.500.13003/27323 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
Pòster a #Docusalut: 🧫🔬Analysis of results of the External Quality Control Program of the SEIMC for the phenotypic detection of carbapenemases https://hdl.handle.net/20.500.13003/27321 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
September 11, 2026 at 4:30 PM
Pòster a #Docusalut: 🧫🔬Analysis of results of the External Quality Control Program of the SEIMC for the phenotypic detection of carbapenemases https://hdl.handle.net/20.500.13003/27321 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
Pòster a #Docusalut: Dual ceftriaxone/azithromycin pressure shapes distinct evolutionary trajectories and selects a hypermutator phenotype in Neisseria gonorrhoeae https://hdl.handle.net/20.500.13003/27320 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
September 11, 2026 at 10:01 AM
Pòster a #Docusalut: Dual ceftriaxone/azithromycin pressure shapes distinct evolutionary trajectories and selects a hypermutator phenotype in Neisseria gonorrhoeae https://hdl.handle.net/20.500.13003/27320 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
Pòster a #Docusalut: Impact of varied resistomes on response of multidrug-resistant Pseudomonas aeruginosa ST235 isolates to ceftazidime/avibactam in monotherapy and combination with... https://hdl.handle.net/20.500.13003/27318 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
September 10, 2026 at 7:30 PM
Pòster a #Docusalut: Impact of varied resistomes on response of multidrug-resistant Pseudomonas aeruginosa ST235 isolates to ceftazidime/avibactam in monotherapy and combination with... https://hdl.handle.net/20.500.13003/27318 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
Pòster a #Docusalut: Implementation of cervical cancer screening by vaginal self-sampling and molecular microbiological detection of high-risk HPV genotypes:... https://hdl.handle.net/20.500.13003/27312 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
September 10, 2026 at 9:02 AM
Pòster a #Docusalut: Implementation of cervical cancer screening by vaginal self-sampling and molecular microbiological detection of high-risk HPV genotypes:... https://hdl.handle.net/20.500.13003/27312 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
Pòster a #Docusalut: MALDI-TOF mass spectrometry coupled with machinelearning for rapid detection of four major high-risk clones of Pseudomonas aeruginosa https://hdl.handle.net/20.500.13003/27312 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
September 9, 2026 at 3:02 PM
Pòster a #Docusalut: MALDI-TOF mass spectrometry coupled with machinelearning for rapid detection of four major high-risk clones of Pseudomonas aeruginosa https://hdl.handle.net/20.500.13003/27312 @idisba.bsky.social #PublicaSalutIB #ESCMIDGlobal #ESCMIDGlobal2026
Over the last two days, the #ESCMIDGlobal Programme Committee has been hard at work shaping the invited programme for next year's congress in Stockholm.
Some exciting new sessions are in the works, and we can't wait to share them with you. Stay tuned...
#ESCMIDGlobal2027
Some exciting new sessions are in the works, and we can't wait to share them with you. Stay tuned...
#ESCMIDGlobal2027
June 16, 2026 at 10:00 AM
Over the last two days, the #ESCMIDGlobal Programme Committee has been hard at work shaping the invited programme for next year's congress in Stockholm.
Some exciting new sessions are in the works, and we can't wait to share them with you. Stay tuned...
#ESCMIDGlobal2027
Some exciting new sessions are in the works, and we can't wait to share them with you. Stay tuned...
#ESCMIDGlobal2027
📢 ESCMID is seeking an Associate Programme Director for #ESCMIDGlobal!
This is a unique opportunity to help shape the scientific programme of ESCMID’s flagship congress.
https://www.escmid.org/fileadmin/escmid/media/pdf/jobs_talents/Open_call_for_ESCMID_Global_Associate_Programme_Director.pdf
This is a unique opportunity to help shape the scientific programme of ESCMID’s flagship congress.
https://www.escmid.org/fileadmin/escmid/media/pdf/jobs_talents/Open_call_for_ESCMID_Global_Associate_Programme_Director.pdf
June 5, 2026 at 4:01 PM
📢 ESCMID is seeking an Associate Programme Director for #ESCMIDGlobal!
This is a unique opportunity to help shape the scientific programme of ESCMID’s flagship congress.
https://www.escmid.org/fileadmin/escmid/media/pdf/jobs_talents/Open_call_for_ESCMID_Global_Associate_Programme_Director.pdf
This is a unique opportunity to help shape the scientific programme of ESCMID’s flagship congress.
https://www.escmid.org/fileadmin/escmid/media/pdf/jobs_talents/Open_call_for_ESCMID_Global_Associate_Programme_Director.pdf
At #ESCMIDGlobal 2026, Professor Tin Tin Myaing highlighted how event-based surveillance and platforms like ProMED-AMR can support earlier detection of emerging infectious disease threats and strengthen AMR surveillance systems.
📍Read more: https://ow.ly/BG6N50Z6M9J
#ProMED #AMR #Epidemiology
📍Read more: https://ow.ly/BG6N50Z6M9J
#ProMED #AMR #Epidemiology
June 4, 2026 at 4:01 PM
At #ESCMIDGlobal 2026, Professor Tin Tin Myaing highlighted how event-based surveillance and platforms like ProMED-AMR can support earlier detection of emerging infectious disease threats and strengthen AMR surveillance systems.
📍Read more: https://ow.ly/BG6N50Z6M9J
#ProMED #AMR #Epidemiology
📍Read more: https://ow.ly/BG6N50Z6M9J
#ProMED #AMR #Epidemiology
🚨New in The Lancet Regional Health – Europe: our highlights from #ESCMIDGlobal 2026, featuring advances in RSV vaccination, post-COVID-19 care, pneumonia diagnosis, and antibiotic stewardship.
Read more 👇 www.thelancet.com/journals/lan...
@escmid.bsky.social
Read more 👇 www.thelancet.com/journals/lan...
@escmid.bsky.social
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026
The 36th Congress of the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID Global) was held in Munich, Germany, from April 17–21. More than
700 sessions were held, with over 17...
www.thelancet.com
May 12, 2026 at 8:34 AM
🚨New in The Lancet Regional Health – Europe: our highlights from #ESCMIDGlobal 2026, featuring advances in RSV vaccination, post-COVID-19 care, pneumonia diagnosis, and antibiotic stewardship.
Read more 👇 www.thelancet.com/journals/lan...
@escmid.bsky.social
Read more 👇 www.thelancet.com/journals/lan...
@escmid.bsky.social
Thanks to the organising committee for a fantastic conference. I had a great time presenting, learning about major developments and discoveries at #ESCMIDGlobal, and reconnecting with colleagues old and new!
Grateful to everyone at @camo-net.bsky.social and Fleming Initiative for all your support!
Grateful to everyone at @camo-net.bsky.social and Fleming Initiative for all your support!
April 24, 2026 at 11:36 PM
Thanks to the organising committee for a fantastic conference. I had a great time presenting, learning about major developments and discoveries at #ESCMIDGlobal, and reconnecting with colleagues old and new!
Grateful to everyone at @camo-net.bsky.social and Fleming Initiative for all your support!
Grateful to everyone at @camo-net.bsky.social and Fleming Initiative for all your support!
The Global-PPS community gathered on 17 April for its annual meeting at #ESCMIDGlobal: over 270 participants engaging in powerful conversations on real-world antimicrobial stewardship.
Plus: 4 research posters on antibiotic use from the Philippines to northern Syria.
-> shorturl.at/PWJ28
Plus: 4 research posters on antibiotic use from the Philippines to northern Syria.
-> shorturl.at/PWJ28
Annual Global-PPS Meeting and ESCMID Global 2026 - Global PPS
Last week, the Global Point Prevalence Survey community gathered for its annual meeting, held in collaboration with bioMérieux at the opening of the ESCMID Global 2026 congress in Munich. With 240 par...
shorturl.at
April 24, 2026 at 12:58 PM
The Global-PPS community gathered on 17 April for its annual meeting at #ESCMIDGlobal: over 270 participants engaging in powerful conversations on real-world antimicrobial stewardship.
Plus: 4 research posters on antibiotic use from the Philippines to northern Syria.
-> shorturl.at/PWJ28
Plus: 4 research posters on antibiotic use from the Philippines to northern Syria.
-> shorturl.at/PWJ28
📣 Parte del equipo investigador de la Fundación ha participado en #ESCMIDGlobal en Múnich 🇩🇪 con ponencias y trabajos científicos.
Seguimos comprometidos con la #investigación y la difusión del conocimiento en congresos internacionales de referencia. 👏
Seguimos comprometidos con la #investigación y la difusión del conocimiento en congresos internacionales de referencia. 👏
April 24, 2026 at 7:01 AM
📣 Parte del equipo investigador de la Fundación ha participado en #ESCMIDGlobal en Múnich 🇩🇪 con ponencias y trabajos científicos.
Seguimos comprometidos con la #investigación y la difusión del conocimiento en congresos internacionales de referencia. 👏
Seguimos comprometidos con la #investigación y la difusión del conocimiento en congresos internacionales de referencia. 👏
I keep telling myself lately that I really shouldn't miss #ESCMIDGlobal and this interesting thread by Onisillos is confirming that. I’ll definitely have to make a plan to attend in the future.🤔
My first session on the last day of #ESCMIDGlobal2026 is Bird flu is no longer just for birds: from strategic planning to public health readiness. The first speaker is Ben Cowling with What drives pandemic risk? Virus, population and policy influencing influenza H1N1 spread
April 21, 2026 at 4:47 PM
I keep telling myself lately that I really shouldn't miss #ESCMIDGlobal and this interesting thread by Onisillos is confirming that. I’ll definitely have to make a plan to attend in the future.🤔
👋Closing out #ESCMIDGlobal
Grateful for the many conversations over the past few days.
🙏 Thank you to everyone who joined us at the booth and poster sessions. Your questions and perspectives are what make these spaces meaningful.
@escmid.bsky.social
Grateful for the many conversations over the past few days.
🙏 Thank you to everyone who joined us at the booth and poster sessions. Your questions and perspectives are what make these spaces meaningful.
@escmid.bsky.social
April 21, 2026 at 4:06 PM
👋Closing out #ESCMIDGlobal
Grateful for the many conversations over the past few days.
🙏 Thank you to everyone who joined us at the booth and poster sessions. Your questions and perspectives are what make these spaces meaningful.
@escmid.bsky.social
Grateful for the many conversations over the past few days.
🙏 Thank you to everyone who joined us at the booth and poster sessions. Your questions and perspectives are what make these spaces meaningful.
@escmid.bsky.social
🤝 This perspective from Jennifer Zinn shared at #ESCMIDGlobal 2026 in Munich really stood out to me.
http://share.biomerieux.com/813h6mG1F6uM #ESCMIDGlobal http://share.biomerieux.com/WoMhk7UoB3xG
http://share.biomerieux.com/813h6mG1F6uM #ESCMIDGlobal http://share.biomerieux.com/WoMhk7UoB3xG
ESCMID 2026 - JENNIFER ZINN VOX POP
share.biomerieux.com
April 20, 2026 at 11:30 PM
🤝 This perspective from Jennifer Zinn shared at #ESCMIDGlobal 2026 in Munich really stood out to me.
http://share.biomerieux.com/813h6mG1F6uM #ESCMIDGlobal http://share.biomerieux.com/WoMhk7UoB3xG
http://share.biomerieux.com/813h6mG1F6uM #ESCMIDGlobal http://share.biomerieux.com/WoMhk7UoB3xG
Just presented at #ESCMIDGlobal
Across 29 gonorrhoea studies in Cambodia, Thailand, Vietnam and South Africa, only 4 include susceptibility data. NAAT-based diagnostics dominate, limiting resistance tracking. Significant surveillance gaps remain.
🤝 Still at Booth G71, come say hi to us!
Across 29 gonorrhoea studies in Cambodia, Thailand, Vietnam and South Africa, only 4 include susceptibility data. NAAT-based diagnostics dominate, limiting resistance tracking. Significant surveillance gaps remain.
🤝 Still at Booth G71, come say hi to us!
April 20, 2026 at 11:31 AM
Just presented at #ESCMIDGlobal
Across 29 gonorrhoea studies in Cambodia, Thailand, Vietnam and South Africa, only 4 include susceptibility data. NAAT-based diagnostics dominate, limiting resistance tracking. Significant surveillance gaps remain.
🤝 Still at Booth G71, come say hi to us!
Across 29 gonorrhoea studies in Cambodia, Thailand, Vietnam and South Africa, only 4 include susceptibility data. NAAT-based diagnostics dominate, limiting resistance tracking. Significant surveillance gaps remain.
🤝 Still at Booth G71, come say hi to us!
Presenting our last poster at #ESCMIDGlobal today.
📍12:00–13:30, Poster Hall B3
Our poster looks at surveillance gaps in gonorrhoea across Cambodia, Thailand, Vietnam and South Africa — from missing regional data to limited resistance insights driven by diagnostic choices.
📍12:00–13:30, Poster Hall B3
Our poster looks at surveillance gaps in gonorrhoea across Cambodia, Thailand, Vietnam and South Africa — from missing regional data to limited resistance insights driven by diagnostic choices.
April 20, 2026 at 6:13 AM
Presenting our last poster at #ESCMIDGlobal today.
📍12:00–13:30, Poster Hall B3
Our poster looks at surveillance gaps in gonorrhoea across Cambodia, Thailand, Vietnam and South Africa — from missing regional data to limited resistance insights driven by diagnostic choices.
📍12:00–13:30, Poster Hall B3
Our poster looks at surveillance gaps in gonorrhoea across Cambodia, Thailand, Vietnam and South Africa — from missing regional data to limited resistance insights driven by diagnostic choices.
🧪📊 We just presented at #ESCMIDGlobal.
Carbapenem-resistant Klebsiella pneumoniae in South Africa isn't a single strain story. We're seeing OXA-48-like enzymes, growing NDM presence and resistance to common treatments, making clinical decisions increasingly difficult.
Carbapenem-resistant Klebsiella pneumoniae in South Africa isn't a single strain story. We're seeing OXA-48-like enzymes, growing NDM presence and resistance to common treatments, making clinical decisions increasingly difficult.
April 19, 2026 at 6:02 PM
🧪📊 We just presented at #ESCMIDGlobal.
Carbapenem-resistant Klebsiella pneumoniae in South Africa isn't a single strain story. We're seeing OXA-48-like enzymes, growing NDM presence and resistance to common treatments, making clinical decisions increasingly difficult.
Carbapenem-resistant Klebsiella pneumoniae in South Africa isn't a single strain story. We're seeing OXA-48-like enzymes, growing NDM presence and resistance to common treatments, making clinical decisions increasingly difficult.
Guideline questions have traditionally come from experts and existing guidelines. Now, patient data, web searches, and LLMs can surface what patients actually ask.
👉 A shift toward truly patient-centred evidence
#ESCMIDGlobal #AIinHealthcare #PatientCentredCare
👉 A shift toward truly patient-centred evidence
#ESCMIDGlobal #AIinHealthcare #PatientCentredCare
April 19, 2026 at 9:07 AM
Guideline questions have traditionally come from experts and existing guidelines. Now, patient data, web searches, and LLMs can surface what patients actually ask.
👉 A shift toward truly patient-centred evidence
#ESCMIDGlobal #AIinHealthcare #PatientCentredCare
👉 A shift toward truly patient-centred evidence
#ESCMIDGlobal #AIinHealthcare #PatientCentredCare
📄 Presenting today at 17:30 in Arena 3 at #ESCMIDGlobal.
Our poster looks at carbapenem-resistant Klebsiella pneumoniae in South Africa where the resistance landscape is far more diverse and complex than a single strain story.
Our poster looks at carbapenem-resistant Klebsiella pneumoniae in South Africa where the resistance landscape is far more diverse and complex than a single strain story.
April 19, 2026 at 8:41 AM
📄 Presenting today at 17:30 in Arena 3 at #ESCMIDGlobal.
Our poster looks at carbapenem-resistant Klebsiella pneumoniae in South Africa where the resistance landscape is far more diverse and complex than a single strain story.
Our poster looks at carbapenem-resistant Klebsiella pneumoniae in South Africa where the resistance landscape is far more diverse and complex than a single strain story.
Here’s a thread on the talk I gave at #ESCMIDGlobal 2026:
“Toilets: Flushing and Spread of Pathogens” — nicknamed “You can’t outrun the plume.” Using published studies, I covered the key components shown below. There’s a surprising amount of data, but still a lack of high-quality intervention trials
“Toilets: Flushing and Spread of Pathogens” — nicknamed “You can’t outrun the plume.” Using published studies, I covered the key components shown below. There’s a surprising amount of data, but still a lack of high-quality intervention trials
April 19, 2026 at 7:49 AM
Here’s a thread on the talk I gave at #ESCMIDGlobal 2026:
“Toilets: Flushing and Spread of Pathogens” — nicknamed “You can’t outrun the plume.” Using published studies, I covered the key components shown below. There’s a surprising amount of data, but still a lack of high-quality intervention trials
“Toilets: Flushing and Spread of Pathogens” — nicknamed “You can’t outrun the plume.” Using published studies, I covered the key components shown below. There’s a surprising amount of data, but still a lack of high-quality intervention trials
Bit overwhelming to be among 15000 microbiologists at #ESCMIDGlobal in #Munich… but fun to see so many friends and colleagues! If you here…. Reach out!
April 18, 2026 at 12:48 PM
Bit overwhelming to be among 15000 microbiologists at #ESCMIDGlobal in #Munich… but fun to see so many friends and colleagues! If you here…. Reach out!
Just presented at #ESCMIDGlobal!
STI guidelines in South Africa are widely followed, but consistent delivery is shaped by workflow and stock realities. Improving guidelines isn't always the main challenge, implementation is. Strong support for new oral gonorrhoea treatments too.
🤝 Visit Booth G71
STI guidelines in South Africa are widely followed, but consistent delivery is shaped by workflow and stock realities. Improving guidelines isn't always the main challenge, implementation is. Strong support for new oral gonorrhoea treatments too.
🤝 Visit Booth G71
April 18, 2026 at 11:42 AM
Just presented at #ESCMIDGlobal!
STI guidelines in South Africa are widely followed, but consistent delivery is shaped by workflow and stock realities. Improving guidelines isn't always the main challenge, implementation is. Strong support for new oral gonorrhoea treatments too.
🤝 Visit Booth G71
STI guidelines in South Africa are widely followed, but consistent delivery is shaped by workflow and stock realities. Improving guidelines isn't always the main challenge, implementation is. Strong support for new oral gonorrhoea treatments too.
🤝 Visit Booth G71
📄 We're presenting our first poster at #ESCMIDGlobal.
📍Poster Hall B3
Our South Africa work looks at how STI guidelines translate into practice and what shapes uptake on the ground. We're also exploring attitudes toward a new oral gonorrhoea treatment.
If you’re at the conference, join us!
📍Poster Hall B3
Our South Africa work looks at how STI guidelines translate into practice and what shapes uptake on the ground. We're also exploring attitudes toward a new oral gonorrhoea treatment.
If you’re at the conference, join us!
April 18, 2026 at 10:37 AM
📄 We're presenting our first poster at #ESCMIDGlobal.
📍Poster Hall B3
Our South Africa work looks at how STI guidelines translate into practice and what shapes uptake on the ground. We're also exploring attitudes toward a new oral gonorrhoea treatment.
If you’re at the conference, join us!
📍Poster Hall B3
Our South Africa work looks at how STI guidelines translate into practice and what shapes uptake on the ground. We're also exploring attitudes toward a new oral gonorrhoea treatment.
If you’re at the conference, join us!